Eyenovia, Inc.
EYENNASDAQHealthcare
$7.56
+$0.29(+3.99%)
Market Cap$38588962
P/E Ratio—
52W High$124.8
52W Low$0.85
Eyenovia, Inc. (EYEN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EYEN · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2025Report Date: Nov 13, 2025EPS Actual
$0.23
Est. -$7.20 · +103.2%
Revenue
$0.00B
Est. $0.00B · -92.4%
Fiscal Period
Q4 FY2025
FY ends December
Report Date
Nov 13, 2025
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
EYEN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 13, 2025 | -$7.20 | $0.23 | +103.2% | $0.00B | $0.00B | -92.4% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -$7.20 | -$14.40 | -100.0% | — | $0.00B | — |
| ▲ Q2 FY2025 | May 19, 2025 | -$9.60 | -$1.59 | +83.4% | $0.00B | $0.00B | -98.5% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -$8.00 | -$14.40 | -80.0% | $0.00B | $0.00B | -98.2% |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$10.40 | -$8.80 | +15.4% | $0.00B | $0.00B | -99.8% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -$13.60 | -$14.40 | -5.9% | $0.00B | $0.00B | -97.5% |
| — Q2 FY2024 | May 15, 2024 | -$14.40 | -$14.40 | +0.0% | $0.00B | $0.00B | -99.4% |
| ▼ Q2 FY2024 | Apr 4, 2024 | -$0.17 | -$0.18 | -5.9% | $0.00B | $0.00B | -97.8% |
Q4 FY2025
Nov 13, 2025Beat
EPS Actual
$0.23
EPS Est.
-$7.20
EPS Surpr.
+103.2%
Revenue
$0.00B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
-$14.40
EPS Est.
-$7.20
EPS Surpr.
-100.0%
Revenue
—
Q2 FY2025
May 19, 2025Beat
EPS Actual
-$1.59
EPS Est.
-$9.60
EPS Surpr.
+83.4%
Revenue
$0.00B
Q1 FY2025
Mar 31, 2025Miss
EPS Actual
-$14.40
EPS Est.
-$8.00
EPS Surpr.
-80.0%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$8.80
EPS Est.
-$10.40
EPS Surpr.
+15.4%
Revenue
$0.00B
Q3 FY2024
Aug 12, 2024Miss
EPS Actual
-$14.40
EPS Est.
-$13.60
EPS Surpr.
-5.9%
Revenue
$0.00B
Q2 FY2024
May 15, 2024
EPS Actual
-$14.40
EPS Est.
-$14.40
EPS Surpr.
+0.0%
Revenue
$0.00B
Q2 FY2024
Apr 4, 2024Miss
EPS Actual
-$0.18
EPS Est.
-$0.17
EPS Surpr.
-5.9%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-3.86 | $-3.86 | $-3.86 | 1 |
| Q3 FY2026 | $-5.44 | $-5.44 | $-5.44 | 1 |
| Q2 FY2026 | $-6.33 | $-6.33 | $-6.33 | 1 |
| Q1 FY2026 | $-7.61 | $-7.61 | $-7.61 | 1 |
| Q4 FY2025 | $-7.20 | $-7.20 | $-7.20 | 1 |
| Q3 FY2025 | $-7.20 | $-7.20 | $-7.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2025 | Nov 13, 2025 | +103.2% | $5.39 | $4.97 | -7.79% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -100.0% | $9.50 | $7.83 | -17.58% |
| ▲ Q2 FY2025 | May 19, 2025 | +83.4% | $1.13 | $1.13 | +0.00% |
| ▼ Q1 FY2025 | Mar 31, 2025 | -80.0% | $1.13 | $1.10 | -2.65% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +15.4% | $37.14 | $40.42 | +8.83% |
| ▼ Q3 FY2024 | Aug 12, 2024 | -5.9% | $68.80 | $70.24 | +2.09% |
| ▲ Q2 FY2024 | May 15, 2024 | +0.0% | $66.10 | $84.80 | +28.29% |
| ▼ Q2 FY2024 | Apr 4, 2024 | -5.9% | $72.03 | $71.47 | -0.78% |
Q4 FY2025-7.79%
Report Date
Nov 13, 2025
EPS Beat/Miss
+103.2%
Price Before
$5.39
Price After
$4.97
Q3 FY2025-17.58%
Report Date
Aug 11, 2025
EPS Beat/Miss
-100.0%
Price Before
$9.50
Price After
$7.83
Q2 FY2025+0.00%
Report Date
May 19, 2025
EPS Beat/Miss
+83.4%
Price Before
$1.13
Price After
$1.13
Q1 FY2025-2.65%
Report Date
Mar 31, 2025
EPS Beat/Miss
-80.0%
Price Before
$1.13
Price After
$1.10
Q4 FY2024+8.83%
Report Date
Nov 12, 2024
EPS Beat/Miss
+15.4%
Price Before
$37.14
Price After
$40.42
Q3 FY2024+2.09%
Report Date
Aug 12, 2024
EPS Beat/Miss
-5.9%
Price Before
$68.80
Price After
$70.24
Q2 FY2024+28.29%
Report Date
May 15, 2024
EPS Beat/Miss
+0.0%
Price Before
$66.10
Price After
$84.80
Q2 FY2024-0.78%
Report Date
Apr 4, 2024
EPS Beat/Miss
-5.9%
Price Before
$72.03
Price After
$71.47
Avg Beat Reaction+7.33%
Avg Miss Reaction-4.73%
Beat Rate4 / 8 quarters
Largest Move+28.29% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EYEN ends December
Eyenovia, Inc. (EYEN) most recently reported earnings on November 13, 2025 for Q4 FY2025, posting EPS of $0.23 — beating the analyst consensus of $-7.20 by +103.2%. The next EYEN earnings date is expected around September 1, 2026.
Each quarter, investors track EYEN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EYEN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EYEN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EYEN earnings · 5 questionsEyenovia, Inc.'s next earnings report is expected around September 1, 2026. EYEN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EYEN historically reports after market close (AMC).
EYEN earnings datewhen is EYEN earningsEYEN next earnings datewhen does EYEN report earningsEYEN earnings calendar
▸ Source: FMP · Eyenovia, Inc. SEC filings · US GAAP · Eyenovia, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026